Exhibit 10.1.40 OPTION AGREEMENT THIS AGREEMENT entered into this 1st day of February 2000 between Neoprobe Corporation, a Delaware corporation with principal offices at 425 Metro Place North, Suite 300, Dublin, Ohio 43017-1331 (hereinafter...Option Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
ARTICLE I DEFINITIONSShare Purchase Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances
1 Exhibit 10.2.55 AGREEMENT, RELEASE AND WAIVER THIS AGREEMENT, RELEASE AND WAIVER (the "Agreement") is a contract between the undersigned employee ("you") who is being involuntarily and without cause, separated from employment on March 31, 2000 (the...Severance Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
1 Exhibit 10.2.56 EMPLOYMENT AGREEMENT This Employment Agreement is made and entered into effective as of April 1, 2000 ("Effective Date), by and between NEOPROBE CORPORATION, a Delaware Corporation with a place of business at 425 Metro Place North,...Employment Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Ohio
Exhibit 10.4.45 MANUFACTURING AND SUPPLY AGREEMENT THIS AGREEMENT entered into this 30th day of March, 2000, between Neoprobe Corporation, 425 Metro Place North, Suite 300, Dublin, Ohio 43017 (hereinafter referred to as ("Neoprobe") and Plexus Corp,...Manufacturing Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • Wisconsin
1 Exhibit 10.1.39 SETTLEMENT AGREEMENT -------------------- January 18, 2000 NEOPROBE CORPORATION, a Delaware corporation ("Neoprobe"); THE ARIES MASTER FUND, a Cayman Island exempted Company ("Master Fund"); THE ARIES DOMESTIC FUND, L.P., a New York...Settlement Agreement • May 15th, 2000 • Neoprobe Corp • In vitro & in vivo diagnostic substances • New York
